AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2019
Aug 2, 2019
32566_dirs_2019-08-02_3ebeacea-3f6f-4e0f-8d00-c2c1eeab2052.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2019-08-01
Reporting Person: Riggsbee Richard Bryan (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-08-01 | Common Stock | S | 25000 | $41.503 | Disposed | 120566 | Direct |
Footnotes
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.
More from MYRIAD GENETICS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 5
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 2